Financhill
Buy
75

DRUG Quote, Financials, Valuation and Earnings

Last price:
$96.00
Seasonality move :
-24.59%
Day range:
$79.50 - $99.71
52-week range:
$23.18 - $123.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
12.68x
Volume:
463.8K
Avg. volume:
213.9K
1-year change:
138.65%
Market cap:
$747.5M
Revenue:
--
EPS (TTM):
-$1.24

Earnings Data

Next earnings date for DRUG
Feb 12
2026
Most recent earnings per share
-$0.41
Beat by $0.31
(Dec 24/2025)
Consensus Estimate
-$0.72
(Dec 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DRUG Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$1.18 --
02/12/2026 Q4 -- -- -- -$0.88 --
12/24/2025 Q3 -- -- -$0.41 -$0.72 $0.31
08/14/2025 Q2 -- -- -$0.53 -$0.65 $0.11
05/15/2025 Q1 -- -- -$0.29 -$0.33 $0.04
02/13/2025 Q4 -- -- $0.01 -$0.35 $0.35
09/30/2024 Q3 -- -- -$0.13 -$0.43 $0.30
06/30/2024 Q2 -- -- $0.04 -- --
03/31/2024 Q1 -- -- -$0.10 -- --
12/31/2023 Q4 -- -- -$0.32 -- --
09/30/2023 Q3 -- -- -$0.30 -- --
06/30/2023 Q2 -- -- -$0.29 -- --
03/31/2023 Q1 -- -- -$0.40 -- --
02/14/2023 Q4 -- -- -$0.48 -- --
09/30/2022 Q3 -- -- -$0.76 -- --
08/30/2022 Q2 -- -- -$0.88 -- --
03/31/2022 Q1 -- -- -$1.50 -- --
02/14/2022 Q4 -- -- -$1.63 -- --
09/30/2021 Q3 -- -- -$0.96 -- --
08/30/2021 Q2 -- -- -$1.22 -- --
03/31/2021 Q1 -- -- -$0.64 -- --
12/31/2020 Q4 -- -- -$0.45 -- --
09/30/2020 Q3 -- -- -$0.24 -- --
06/30/2020 Q2 -- -- -$0.02 -- --
03/31/2020 Q1 -- -- -$0.00 -- --
12/31/2019 Q4 -- -- -$0.02 -- --

Bright Minds Biosciences, Inc. Earnings Questions

  • How Much did Bright Minds Biosciences, Inc. Generate in Revenue Last Quarter?

    Bright Minds Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Bright Minds Biosciences, Inc. Beat Earnings Last Quarter?

    Bright Minds Biosciences, Inc. announced earnings per share of -$0.41 which represents a beat of analyst forecast a -$0.72 per share.

  • Is Bright Minds Biosciences, Inc. Profitable?

    Bright Minds Biosciences, Inc. reported -$12.3K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Bright Minds Biosciences, Inc. EPS Next Year?

    Bright Minds Biosciences, Inc.'s earnings are forecast to decrease from -$1.27 per share to -$1.67 per share next year representing a decrease of -278.42%.

  • When is Bright Minds Biosciences, Inc.'s Earnings Date?

    Bright Minds Biosciences, Inc.'s next earnings date is February 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
5
SMX alert for Jan 8

SMX (Security Matters) Plc [SMX] is up 76.4% over the past day.

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is up 58.95% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 28.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock